Treatment Considerations

At its simplest, treatment of patients with chronic multiple SUDs requires a focus upon each disorder separately, in addition to providing patients with a coherent overall rationale and approach to addiction treatment. Although multiple SUDs have a net negative impact on treatment outcome, Abellanas and McLellan (1993) have shown that patients with multiple SUDs report generally similar motivation for change across drugs of abuse, meaning that their desire to modify their substance use remains consistent across substances. An additional issue is the specific impact of other substance use upon recovery for a particular SUD. Treatment is thus best constructed with a bottom-up approach, using evidence-based approaches where available (Rosenthal, 2004), rather than assuming that optimal treatment should be largely psychotherapeutic or pharmacotherapeutic. For example, there is a clear evidence base for the use of methadone as an agonist therapy for stabilization of opioid dependence (Ciraulo, 2003). However, there is not good evidence that an adequate dose of methadone for treating opioid dependence will suffice in treating cocaine abuse or dependence. Since there is no approved pharmacotherapy for cocaine use disorders at present, the optimal therapy should come from the behavioral treatments, which also have an evidence base. As such, the approach to treating patients with opioid dependence and cocaine dependence should have both pharmacotherapeutic and psychotherapeutic components.

In the acute setting, multiple SUDs present the treatment team with significant challenges. Given a patient's complicated history of recent and chronic use of multiple substances, the clinician in the emergency room or detoxification unit often struggles to make treatment priorities out of a constellation of signs and symptoms that may be the result of intoxication or withdrawal from a number of substances. Given the frequent occurrence of multiple substance use diagnoses (particularly between alcohol and other drugs), any attempt to attribute observed findings associated with comorbid substance use to a single substance, or class of substances, is often difficult, if not impossible. Intoxication from stimulants may result in psychotic symptoms, but so does withdrawal from sedatives. Lethargy is not only a classic sign of opioid intoxication but also a consequence of stimulant withdrawal. A patient who currently uses both benzo-diazepines and crystal methamphetamine, and presents with seizures, may be either acutely intoxicated with methamphetamine or suffering from severe benzodiazepine withdrawal, or both. Furthermore, the serious psychosocial complications of multiple SUDs add significantly to the difficulty in treating the already confusing biological manifestations of the illness. As in the case of relapse prevention, the successful management of acute multiple substance use relies primarily upon identification and treatment of each intoxication and withdrawal syndrome separately. For example, patients with serious withdrawal from heroin and alcohol typically require both opioid agonists (e.g., methadone or buprenophine) and benzodiazepines (e.g., chlordiazapoxide or lorazepam), with particular attention to potential synergistic effects between the two classes of medications.


Abellanas, L., & McLellan, A. T. (1993). "Stage of change" by drug problem in concurrent opioid, cocaine, and cigarette users. J Psychoactive Drugs, 25, 307-313.

Ananth, J., Vandeater, S., Kamal, M., & Brodsky, A. (1989). Missed diagnosis of substance abuse in psychiatric patients. Hosp Community Psychiatry, 40, 297-299.

American Psychiatric Association. (1980). Diagnostic and statistical manual of mental disorders (3rd ed.). Washington, DC: Author.

American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders (3rd ed., rev.). Washington, DC: Author.

American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.

American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author.

Babor, T. F., Hofmann, M., DelBoca, F. K., Hesselbrock, V., Meyer, R. E, Dolinsky, Z. S., & Rounsaville, B. (1992). Types of alcoholics: I. Evidence for an empirically derived typology based on indicators of vulnerability and severity. Arch Gen Psychiatry, 49, 599-608.

Ball, S. A., Carroll, K. M., Babor, T. F., & Rounsaville, B. J. (1995). Subtypes of cocaine abusers: Support for a Type A-Type B distinction. J Consult Clin Psychol,

Ball, S. A., Carroll, K. M., & Rounsaville, B. J. (1994). Sensation seeking, substance abuse, and psychopathology in treatment-seeking and community cocaine abusers. J Consult Clin Psychol, 62, 1053-1057.

Ball, S. A., Kranzler, H. R., Tennen, H., Poling, J. C., & Rounsaville, B. J. (1998). Personality disorder and dimension differences between Type A and type B substance abusers. J Pers Disord, 12, 1-12.

Beatty, W. W., Blanco, C. R., Hames, K. A., &Nixon, S. J. (1997). Spatial cognition in alcoholics: Influence of concurrent abuse of other drugs. Drug Alcohol Depend, 44,


Bechara, A. (1999). Different contributions of the human amygdala and ventromedial prefrontal cortex to decision-making. J Neurosci, 19, 5473-5481.

Bierut, L. J., Dinwidie, S. H., Begleiter, H., Crowe, R. R., Hesselbrock, V., Nurnberger, J. I., et al. (1998). Familial transmission of substance dependence: Alcohol, marijuana, cocaine and habitual smoking. Arch Gen Psychiatry, 55, 982-988.

Block, R. I., Erwin, W. J., & Ghoneim, M. M. (2002). Chronic drug use and cognitive impairments. Pharmacol Biochem Behav, 73, 491-504.

Bondi, M. W., Drake, A. I., & Grant, I. (1998). Verbal learning and memory in alcohol abusers and polysubstance abusers with concurrent alcohol abuse. J Int Neuropsy-chol Soc, 4, 319-328.

Brook, D. W., Brook, J. S., Zhang, C., Cohen, P., & Whiteman, M. (2002). Drug use and the risk of major depressive disorder, alcohol dependence, and substance use disorders. Arch Gen Psychiatry, 59, 1039-1044.

Brooner, R. K., King, V. L., Kidorf, M., Schmidt, C. W., & Bigelow, G. E. (1997). Psychiatric and substance use comorbidity among treatment seeking opioid abusers. Arch Gen Psychiatry, 54, 71-80.

Caetano, R., & Weisner, C. (1995). The association between DSM-III-R alcohol dependence, psychological distress and drug use. Addiction, 90, 351-359.

Casillas, A., & Clark, L. A. (2002). Dependency, impulsivity, and self-harm: Traits hypothesized to underlie the association between cluster B personality and substance use disorders. J Personal Disord, 16, 424-436.

Ciraulo, D. A. (2003). Outcome predictors in substance use disorders. Psychiatr Clin N Am, 26, 381-409.

Clemmey, P., Brooner, R., Chutuape, M. A., Kidorf, M., & Stitzer, M. (1997). Smoking habits and attitudes in a methadone maintenance treatment population. Drug Alcohol Depend, 44, 123-132.

Cloninger, C. R. (1987). A systematic method for clinical description and classification of personality variants. Arch Gen Psychiatry, 44, 573-588.

Cloninger, C. R., Sigvardsson, S., & Bohman, M., (1988). Childhood personality predicts alcohol abuse in young adults. Alcohol Clin Exp Res, 12, 494-505.

Cohen, R. S. (1998). The Love Drug: Marching to the beat of Ecstasy. Binghamton, NY: Haworth Medical Press.

Cone, E. J., Fant, R. V., Rohay, J. M., Caplan, Y. H., Ballina, M., Reder, R. F., et al. (2003). Oxycodone involvement in drug abuse deaths: A DAWN-based classification scheme applied to an oxycodone postmortem database containing over 1000 cases. J Anal Toxicol, 27, 57-67.

Conway, K. P., Kane, R. J., Ball, S. A., Poling, J. C., & Rounsaville, B. J. (2003). Personality, substance of choice, and polysubstance involvement among substance dependent patients. Drug Alcohol Depend, 71, 65-75.

Conway, K. P., Swendson, J. D., Rounsaville, B. J., & Merikangas, K. R. (2002). Personality, drug of choice, and comorbid psychopathology among substance abusers. Drug Alcohol Depend, 65, 225-234.

Cook, P. A., Clark, P., Bellis, M. A., Ashton, J. R., Syed, Q., Hoskins, A., et al. (2001). Re-emerging syphilis in the UK: A behavioral analysis of infected individuals. Commun Dis Public Health, 4, 253-258.

Cunningham, S. C., Corrigan, S. A., Malow, R. M., & Smason, I. H. (1993). Psycho-pathology in inpatients dependent on cocaine or alcohol and cocaine. Psychol Addict Behav, 7, 246-250.

Darke, S., & Hall, W. (1995). Levels and correlates of polydrug use among heroin users and regular amphetamine users. Drug Alcohol Depend, 39, 231-235.

Darke, S., & Hall, W. (2003). Heroin overdose: Research and evidence-based intervention. J Urban Health, 80, 189-200.

Darke, S., & Ross, J. (1997). Polydrug dependence and psychiatric comorbidity among heroin injectors. Drug Alcohol Depend, 48, 135-141.

Darke, S., & Ross, J. (2000). The use of antidepressants among injecting drug users in Sydney, Australia. Addiction, 95, 407-417.

Darke, S., Williamson, A., Ross, J., Teesson, M., & Lynskey, M. (2004). Borderline per sonality disorder, antisocial personality disorder and risk-taking among heroin users: Findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Depend, 74, 77-83.

Darke, S., & Zador, D. (1996). Fatal heroin overdose: A review. Addiction, 91, 17651772.

Dinwiddie, S. H., Cottler, L., Compton, W., & Abdallah, A. B. (1996). Psychopatholo-gy and HIV risk among injection drug users in and out of treatment. Drug Alcohol Depend, 43, 1-11.

Earleywine, M., & Newcomb, M. D. (1997). Concurrent versus simultaneous polydrug use: Prevalence, correlates, discriminant validity and prospective effects on health outcomes. Exp Clin Pharm, 5, 353-364.

Edens, J. F., & Willoughby, F. W. (1999). Motivational profiles of polysubstance-dependent patients: Do they differ from alcohol-dependent patients? Addict Behav,

Epstein, D. H., & Preston, K. L. (2003). Does cannabis use predict poor outcome for heroin-dependent patients on maintenance treatment?: Past findings and more evidence against. Addiction, 98, 269-279.

Feingold, A., Ball, S. A., Kranzler, H. R., & Rounsaville, B. J. (1996). Generalizability of the type A/type B distinction across different psychoactive substances. Am J. Drug Alcohol Abuse, 22, 449-462.

First, M. B., & Pincus, H. A. (2002). The DSM-IV text revision: Rationale and potential impact on clinical practice. Psychiatr Serv, 53, 288-292.

Grant, B., & Hartford, T. (1990). Concurrent and simultaneous use of alcohol with sedatives and tranquilizers: Results of a national survey. J Subst Abuse, 2, 1-14.

Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Ruan, W. J., & Pickering, R. P. (2004). Co-occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry, 61, 361-368.

Grant, S., Contoreggi, C., & London, E. D. (2000). Drug abusers show impaired performance in a laboratory test of decision making. Neuropsychologia, 38, 1180-1187.

Greenwood, G. L., White, E. W., Page-Shafer, K., Bein, E., Osmond, D. H., Paul, J., & Stall, R. D. (2001). Correlates of heavy substance use among young gay and bisexual men: The San Francisco Young Men's Health Study. Drug Alcohol Depend, 61, 105-112.

Harrington, R. D., Woodward, J. A., Hooton, T. M., & Horn, J. R. (1999). Life-threatening interactions between HIV-1 protease inhibitors and the illicit drugs MDMA and gamma-hydroxybutyrate. Arch Intern Med, 159, 2221-2224.

Helzer, J. E., & Pryzbeck, T. R. (1988). The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. J Stud

Alcohol, 49, 219-224.

Hien, D., Zimberg, S., Weisman, S., First, M., & Ackerman, S. (1997). Dual diagnosis subtypes in urban substance abuse and mental health clinics. Psychiatr Serv, 48, 1058-1063.

Hopfer, C. J., Khuri, E., Crowley, T. J., & Hooks, S. (2002). Adolescent heroin use: A review of the descriptive and treatment literature. J Subst Abuse Treat, 23, 231237.

Jordan, B. K., Schlenger, W. E., Fairbank, J. A., & Caddell, J. M. (1996). Prevalence of psychiatric disorders among incarcerated women: II. Convicted felons entering prison. Arch Gen Psychiatry, 53, 513-519.

Kandel, D., Chen, K., Warner, L. A., Kessler, R. C., & Grant, B. (1997). Prevalence and demographic correlates of symptoms of last year dependence on alcohol, nicotine, marijuana and cocaine in the U.S. population. Drug Alcohol Depend, 44, 1129.

Kessler, R. C., Crum, R. M., Warner, L. A., Nelson, C. B., Schulenberg, J., & Anthony, J. C. (1997). Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Study. Arch Gen Psychiatry, 54, 313-321.

Kessler, R. C., McGonagle, K. A., Zhao, S., Nelson, C. B., Hughes, M., Eshelman, S., et al. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Study. Arch Gen Psychiatry, 51, 8-19.

Kidorf, M., Brooner, R. K., King, V. L., Chutuape, M. A., & Stitzer, M. L. (1996). Concurrent validity of cocaine and sedative dependence diagnoses in opioid-dependent outpatients. Drug Alcohol Depend, 42, 117-123.

Kleinman, P. H., Miller, A. B., Millman, R. B., Woody, G. E., Todd, T., Kemp, J., & Lipton, D. S. (1990). Psychopathology among cocaine abusers entering treatment. J Nerv Ment Dis, 178, 442-447.

Kokkevi, A., & Stefanis, C. (1995) Drug abuse and psychiatric comorbidity. Compr Psychiatry, 36, 329-333.

Kranzler, H. R., Satel, S., & Apter, A. (1994). Personality disorder and associated features in cocaine-dependent inpatients. Compr Psychiatry, 35, 335-340.

Kruedelbach, N., McCormick, R. A., Schulz, S. C., &Grueneich, R. (1993). Impulsivi-ty, coping styles, and triggers for craving in substance abusers with borderline personality disorder. J Personal Disord, 7, 214-222.

Leal, J., Ziedonis, D., & Kosten, T. (1994). Antisocial personality disorder as a prognostic factor for pharmacotherapy of cocaine dependence. Drug Alcohol Depend, 35, 31-35.

Lee, S. J., Galanter, M., Dermatis H., & McDowell D. (2003). Circuit parties and patterns of drug use in a subset of gay men. J Addict Dis, 22, 47-60.

Leri, F., Bruneau, J., & Stewart, J. (2003). Understanding polydrug use: Review of heroin and cocaine co-use. Addiction, 98, 7-22.

Levin, F. R., Foltin, R. W., & Fischman, M. W. (1996). Pattern of cocaine use in methadone-maintained individuals applying for research studies. J Addict Dis, 15, 97-106.

Levounis, P., Galanter, M., Dermatis, H., Hamowy, A., & De Leon, G. (2003). Correlates of HIV transmission risk factors and considerations for interventions in homeless, chemically addicted and mentally ill patients. J Addict Dis, 21, 61-72.

Magura, S., Kang, S. Y., Nwakeze, P. C., & Demsky, S. (1998). Temporal patterns of heroin and cocaine use among methadone patients. Subst Use Misuse, 33, 24412467.

Malow, R. M., West, J. A., Corrigan, S. A., Pena, J. M., & Lott, W. C. (1992). Cocaine and speedball users: differences in psychopathology. J Subst Abuse Treatment, 9, 287-292.

Mansergh, G., Colfax, G. N., Marks, G., Rader, M., Guzman, R., & Buchbinder, S.

(2001). The Circuit Party Men's Health Survey: Findings and implications for gay and bisexual men. Am J Public Health, 91, 953-958.

Marlowe, D. B., Husband, S. D., Lamb, R. J., Kirby, K. C., Iguchi, M. Y., & Platt, J. J. (1995). Psychiatric comorbidity in cocaine dependence: Diverging trends, Axis II spectrum and gender differentials. Am J Addict, 4, 70-81.

Mattison, A. M., Ross, M. W., Wolfson, T., Franklin, D., & San Diego HIV Neuro-behavioral Research Center Group. (2001). Circuit party attendance, club drug use, and unsafe sex in gay men. J Subst Abuse, 31, 119-126.

McCormick, R. A., Dowd, E. R., Quirt, S., & Zegarra, J. H. (1998). The relationship of NEO-PI performance to coping styles, patterns of use, and triggers for use among substance abusers. Addict Behav, 23, 497-507.

McCormick, R. A., & Smith, M. (1995). Aggression and hostility in substance abusers: The relationship to abuse patterns, coping style, and relapse triggers. Addict Behav,

Medina, K. L., Shear, P. K., Schafer, J., Armstrong, T. G., & Dyer, P. (2004). Cognitive functioning and length of abstinence in polysubstance dependent men. Arch Clin Neuropsychol, 19, 245-258.

Merikangas, K. R., Stolar, M., Stevens, D. E., Goulet, J., Preisig, M. A., Fenton, B., et al. (1998). Familial transmission of substance use disorders. Arch Gen Psychiatry, 55, 973-979.

Morgenstern, J., Langenbucher, J., Labouvie, E., & Miller, K. J. (1997). The comor-bidity of alcoholism and personality disorders in a clinical population: Prevalence rates and relation to alcohol typology variables. J Abnorm Psychol, 106, 7484.

Mors, O., & Sorensen, L. V. (1994). Incidence and comorbidity of personality disorders among first ever admitted psychiatric patients. Eur Psychiatry, 9, 175-184.

O'Boyle, M., & Barratt, E. S. (1993). Impulsivity and DSM-III-R personality disorders. Pers Individ Dif, 14, 609-611.

Parrott, A. C., Milani, R., Parmar, R., & Turner, J. J. D. (2001). Ecstasy polydrug users and other recreational drug users in Britain and Italy: Psychiatric symptoms and psychobiological problems. Psychopharmacology, 159, 77-82.

Parrott, A. C., Sisk, E., & Turner, J. (2000). Psychobiological problems in heavy "Ecstasy" (MDMA) polydrug users. Drug Alcohol Depend, 60, 105-110.

Pedersen, W., Clausen, S. E., & Lavik, N. J. (1989). Patterns of drug use and sensation seeking among adolescents in Norway. Acta Psychiatr Scand, 39, 386-390.

Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L., & Goodwin, F. K. (1990). Comorbidity of mental disorder with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) study. JAMA, 264, 2511-2518.

Ritsher, J. B., Moos, R. H., & Finney, J. W. (2002). Relationship of treatment orientation and continuing care to remission among substance abuse patients. Psychiatr Serv, 53(5), 595-601.

Rodgers, J. (2000). Cognitive performance amongst recreational users of "Ecstasy." Psychopharmacology, 151, 19-24.

Rosenthal, R. N. (2004). Concepts of evidence based practice. In A. R. Roberts & K. R. Yeager (Eds.), Evidence-based practice manual: Research and outcome measures in health and human services (pp. 20-29). New York: Oxford University Press.

Rosenthal, R. N., Hellerstein, D. J., & Miner, C. R. (1992). Integrated services for treatment of schizophrenic substance abusers: Demographics, symptoms, and substance abuse patterns. Psychiatr Q, 63, 3-26.

Rosenthal, R. N., & Solhkhah, R. (in press). Neurobiologic and clinical properties of the "club drugs." In H. R. Kranzler & D. A. Ciraulo (Eds.), Clinical manual of addiction psychopharmacology. Arlington, VA, American Psychiatric Press.

Rosenthal, R. N., & Westreich, L. (1999). Treatment of persons with dual diagnoses of substance use disorder and other psychological problems. In B. S. McCrady & E. E. Epstein (Eds.), Addictions: A comprehensive guidebook (pp. 439-476). New York: Oxford University Press.

Ross, L., Kohler, C. L., Grimley, D. M., & Bellis, J. (2003). Intention to use condoms among three low-income, urban African American subgroups: Cocaine users, noncocaine drug users, and non-drug users. J Urban Health, 80(1), 147-160.

Rounsaville, B. J., Dolinsky, Z. S., Babor, T. F., & Meyer, R. E. (1987). Psychopatholo-gy as a predictor of treatment outcome in alcoholism. Arch Gen Psychiatry, 44, 505-513.

Rounsaville, B. J., Kosten, T. R., Weissman, M. M., Prusoff, B., Pauls, D., Anton, S. F., & Merikangas, K. (1991). Psychiatric disorders in relatives of probands with opiate addiction. Arch Gen Psychiatry, 48, 33-42.

Rounsaville, B. J., Kranzler, H. R., Ball, S., Tennen, H., Poling, J., & Triffleman, E. (1998). Personality disorders in substance abusers: Relation to substance use. J Nerv Ment Dis, 186, 87-95.

Schifano, F., Di Furia, L., Forza, G., Minicuci, N., & Bricolo, R. (1998). MDMA ("Ecstasy") consumption in the context of polydrug abuse: A report on 150 patients. Drug Alcohol Depend, 52, 85-90.

Scholey, A. B., Parrott, A. C., Buchanan, T., Heffernan, T. M., Ling, J., & Rodgers, J. (2004). Increased intensity of ecstasy and polydrug usage in the more experienced recreational ecstasy/MDMA users: A WWW study. Addict Behav, 29, 743-752.

Schuckit, M. A., Danko, G. P., Raimo, E. B., Smith, T. L., Eng, M. Y., Carpenter, K. K., & Hesselbrock, V. M. (2001). A preliminary evaluation of the potential usefulness of the diagnoses of polysubstance dependence. J Stud Alcohol, 62, 54-61.

Selby, M. J., & Azrin, R. L. (1998). Neuropsychological functioning in drug abusers. Drug Alcohol Depend, 50, 39-45.

Skinstad, A. H., & Swain, A. (2001). Comorbidity in a clinical sample of substance abusers. Am J Drug Alcohol Abuse, 27, 45-64.

Staines, G. L., Magura, S., Foote, J., Deluca, A., & Kosanke, N. (2001). Polysubstance use among alcoholics. J Addict Dis, 20, 53-69.

Substance Abuse and Mental Health Services Administration, Office of Applied Studies. (2003a). National Survey of Substance Abuse Treatment Services (N-SSATS): 2002 [Data on Substance Abuse Treatment Facilities, DASIS Series: S-19, DHHS Publication No. (SMA) 03-3777]. Rockville, MD: U.S. Dept. of Health and Human Services.

Substance Abuse and Mental Health Services Administration, Office of Applied Studies. (2003b). Treatment Episode Data Set (TEDS): 1992-2001 [National Admissions to Substance Abuse Treatment Services, DASIS Series: S-20, DHHS Publication No. (SMA) 03-3778]. Rockville, MD: U.S. Dept. of Health and Human Services.

Tomasson, K., & Vaglum, P. (2000). Antisocial addicts: The importance of additional Axis I disorders for the 28-month outcome. Eur Psychiatry, 15, 443-449.

Trull, T. J., Sher, K. J., Minks-Brown, C., Durbin, J., & Burr, R. (2000). Borderline personality disorder and substance use disorders: A review and integration. Clin Psychol Rev, 20, 235-253.

Tsuang, M. T., Lyons, M. J., Eisen, S. A., Goldberg, J., True, W., Lin, N., et al. (1996). Genetic influences on DSM-III-R drug abuse and dependence: A study of 3,372 twin pairs. Am J Med Genet, 67, 473-477.

Tsuang, M. T., Lyons, M. J., Meyer, J. M., Doyle, T., Eisen, S. A., Goldberg, J., et al. (1998). Co-occurrence of abuse of different drugs in men: The role of drug-specific and shared vulnerabilities. Arch Gen Psychiatry, 55, 967-972.

Tyler, A. (1995). Street drugs. London, UK: Hodder & Stoughton.

Vreugdenhil, C., Van Den Brink, W., Wouters, L. F., & Doreleijers, T. A. (2003). Substance use, substance use disorders, and comorbidity patterns in a representative sample of incarcerated male Dutch adolescents. J Nerv Ment Dis, 191, 372-378.

Walton, M. A., Blow F. C., & Booth, B. M. (2000). A comparison of substance abuse patients' and counselors' perceptions of relapse risk: Relationship to actual relapse. J Subst Abuse Treatment, 19, 161-169.

Webb, J. A., Baer, P. E., & McKelvey, R. S. (1995). Development of a risk profile for intentions to use alcohol among fifth and sixth graders. J Am Acad Child Adolesc Psychiatry, 34, 772-778.

Weizman, T., Gelkopf, M., Melamed, Y., Adelson, M., & Bleich, A. (2004). Cannabis abuse is not a risk factor for treatment outcome in methadone maintenance treatment: A 1-year prospective study in an Israeli clinic. Aust NZJ Psychiatry, 38, 4246.

Woody, G. E., McLellan, A. T., Luborsky, L., & O'Brien, C. P. (1985). Sociopathy and psychotherapy outcome. Arch Gen Psychiatry, 42, 1081-1086.

Anxiety and Depression 101

Anxiety and Depression 101

Everything you ever wanted to know about. We have been discussing depression and anxiety and how different information that is out on the market only seems to target one particular cure for these two common conditions that seem to walk hand in hand.

Get My Free Ebook

Post a comment